AU2001275820A1 - Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same - Google Patents

Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same

Info

Publication number
AU2001275820A1
AU2001275820A1 AU2001275820A AU7582001A AU2001275820A1 AU 2001275820 A1 AU2001275820 A1 AU 2001275820A1 AU 2001275820 A AU2001275820 A AU 2001275820A AU 7582001 A AU7582001 A AU 7582001A AU 2001275820 A1 AU2001275820 A1 AU 2001275820A1
Authority
AU
Australia
Prior art keywords
fetal
diagnostic
same
kit containing
prenatal diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275820A
Other languages
English (en)
Inventor
Bo Hyun Yoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seoul National University Industry Foundation
Original Assignee
Seoul National University Industry Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seoul National University Industry Foundation filed Critical Seoul National University Industry Foundation
Publication of AU2001275820A1 publication Critical patent/AU2001275820A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU2001275820A 2000-11-21 2001-08-01 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same Abandoned AU2001275820A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2000-0069283A KR100425525B1 (ko) 2000-11-21 2000-11-21 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트
KR0069283 2000-11-21
PCT/KR2001/001306 WO2002042770A1 (en) 2000-11-21 2001-08-01 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same

Publications (1)

Publication Number Publication Date
AU2001275820A1 true AU2001275820A1 (en) 2002-06-03

Family

ID=19700313

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275820A Abandoned AU2001275820A1 (en) 2000-11-21 2001-08-01 Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same

Country Status (7)

Country Link
US (1) US7232661B2 (cg-RX-API-DMAC7.html)
EP (1) EP1336103A4 (cg-RX-API-DMAC7.html)
JP (1) JP4011479B2 (cg-RX-API-DMAC7.html)
KR (1) KR100425525B1 (cg-RX-API-DMAC7.html)
CN (1) CN1245626C (cg-RX-API-DMAC7.html)
AU (1) AU2001275820A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002042770A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2231791C2 (ru) * 2002-09-26 2004-06-27 Ахмадеева Эльза Набиахметовна Способ диагностики внутриутробной инфекции новорожденных
GB2435510A (en) 2006-02-23 2007-08-29 Mologic Ltd Enzyme detection product and methods
GB2435512A (en) * 2006-02-23 2007-08-29 Mologic Ltd A binding assay and assay device
GB2435511A (en) 2006-02-23 2007-08-29 Mologic Ltd Protease detection
GB2437311A (en) * 2006-04-07 2007-10-24 Mologic Ltd A protease detection product
EP2083863B1 (en) * 2006-10-03 2015-03-18 Genzyme Corporation Antibodies to tgf-beta for use in the treatment of infants at risk of developing bronchopulmonary dysplasia
WO2008137567A1 (en) * 2007-05-01 2008-11-13 Cedars-Sinai Medical Center Caspase inhibitors in the treatment of infection-associated preterm delivery
CN110208540B (zh) * 2008-10-31 2024-02-09 耶鲁大学 子痫前期检测和治疗的方法和组合物
EP2510356B1 (en) * 2009-12-08 2018-10-31 Cedars-Sinai Medical Center Diagnostic method to identify women at risk for preterm delivery
ES2614059T3 (es) 2011-03-17 2017-05-29 Cedars-Sinai Medical Center Biomarcador de diagnóstico para predecir las mujeres en riesgo de parto prematuro
EP2997370A4 (en) * 2013-05-16 2017-01-18 Basetra Medical Technology Co. Ltd. Fetal diagnostics using fetal cell capture from maternal blood
US20160130553A1 (en) 2014-05-15 2016-05-12 Kellbenx Incorporated PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
US12202890B1 (en) 2014-11-07 2025-01-21 Kellbenx Incorporated Antibodies for detection and enrichment of fetal cells and their use
CN104498431B (zh) * 2015-01-23 2017-10-20 温州市中心医院 一种载玻片原位培养羊水细胞及核型处理分析的方法
KR101578526B1 (ko) * 2015-07-14 2015-12-17 이화여자대학교 산학협력단 32주 미만의 조산 위험성을 예측하기 위한 마커 il-13 및 이의 이용
KR101695347B1 (ko) 2015-10-12 2017-01-11 이화여자대학교 산학협력단 유전자의 CpG 메틸화 변화를 이용한 조산 위험성 예측용 조성물 및 이의 이용
KR101589673B1 (ko) * 2015-10-12 2016-01-28 (주)휴레이포지티브 시약 키트의 이미지를 통한 감염병 진단 방법 및 장치
AU2016349390A1 (en) 2015-11-06 2018-05-10 Amnion Life, LLC Premature infant amniotic bath incubator
US20200191801A1 (en) * 2016-12-23 2020-06-18 Susanne PANGRATZ-FÜHRER Alpha-b crystallin in the diagnosis of neonatal brain damage
WO2018220129A1 (en) 2017-05-31 2018-12-06 B.R.A.H.M.S Gmbh Mmp-8 as a marker for identifying infectious disease
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
EP3682247B1 (en) 2017-09-13 2022-02-09 B.R.A.H.M.S GmbH Proadrenomedullin as a marker for abnormal platelet levels
EP3502706A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
RU2687486C1 (ru) * 2018-02-05 2019-05-14 Федеральное государственное бюджетное образовательное учреждение высшего образования Кубанский государственный медицинский университет Министерства Здравоохранения Российской Федерации (ФГБОУ ВО КУбГМУ МЗ РФ) Способ определения степени риска внутриутробной инфекции плода у женщин, перенесших грипп A(H1N1) в период беременности
KR102184911B1 (ko) * 2019-06-07 2020-12-01 한림대학교 산학협력단 miR-548을 함유하는 조산 예방 또는 치료제 조성물
CN111513729B (zh) * 2020-05-07 2021-04-27 吉林大学 一种高效的产前诊断间期胎儿细胞检测装置
KR102339013B1 (ko) * 2020-11-16 2021-12-14 주식회사 옵티바이오 양수 검체 내 mmp-8 정량화가 가능한 체외 진단 키트
KR20240083552A (ko) 2022-12-05 2024-06-12 주식회사 제이스텍 진단키트용 비드의 공급 및 투입장치

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor

Also Published As

Publication number Publication date
US20040029176A1 (en) 2004-02-12
CN1476537A (zh) 2004-02-18
CN1245626C (zh) 2006-03-15
WO2002042770A1 (en) 2002-05-30
JP4011479B2 (ja) 2007-11-21
KR100425525B1 (ko) 2004-03-30
KR20020039458A (ko) 2002-05-27
US7232661B2 (en) 2007-06-19
EP1336103A4 (en) 2007-05-09
JP2004522942A (ja) 2004-07-29
EP1336103A1 (en) 2003-08-20

Similar Documents

Publication Publication Date Title
AU2001275820A1 (en) Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same
AU2001248550A1 (en) Non-invasive prenatal diagnosis using cd45-ve fetal cells
AU2002314224A1 (en) Prenatal diagnosis method on isolated foetal cell of maternal blood
GB9904585D0 (en) Clinical and diagnostic database
AUPR005600A0 (en) Diagnostic assay
AUPR044000A0 (en) Diagnostic device
AU2002317454A1 (en) Methods and apparatus for objective fetal diagnosis
AU5567299A (en) Hand held ultrasonic diagnostic instrument
AU4522201A (en) Cryopreservation compositions and methods for peripheral blood lymphocytes
AUPR509601A0 (en) Diagnostic feature extraction in dermatological examination
AU6735600A (en) Multipurpose diagnostic systems using protein chips
AU2002346086A1 (en) Diagnostic imaging tabletop
AU2001278808A1 (en) Diagnostic device for distinguishing between normal and ectopic pregnancy and method for preparing the same
AU2002324881A1 (en) Diagnostic and prognostic tests
WO2003084384A3 (en) Diagnosis of flavivirus infection
AU3760400A (en) Methods and reagents for the diagnosis and treatment of multiple sclerosis
EP1458328A4 (en) FORMULATIONS FOR USE IN MEDICAL AND DIAGNOSTIC PROCEDURES
AU1238501A (en) Process for consumer-directed diagnostic and health care information
AU3460800A (en) Method of bleaching blood samples, diagnostic method and diagnostic kit using the same
AU3697899A (en) Diagnostic agent for mr diagnosis
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU1163101A (en) Diagnostic methods
AU6835300A (en) Diagnostic kit and use thereof
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2001280732A1 (en) Pregnancy and sex identification test based on saliva or other bodily fluids